Page last updated: 2024-11-04

temozolomide and Polydipsia

temozolomide has been researched along with Polydipsia in 1 studies

Polydipsia: Excessive thirst manifested by excessive fluid intake. It is characteristic of many diseases such as DIABETES MELLITUS; DIABETES INSIPIDUS; and NEPHROGENIC DIABETES INSIPIDUS. The condition may be psychogenic in origin.

Research Excerpts

ExcerptRelevanceReference
"Temozolomide (TMZ) is an alkylating agent primarily used to treat tumors of the central nervous system."5.39Central diabetes insipidus: a previously unreported side effect of temozolomide. ( Faje, AT; Klibanski, A; Makimura, H; Miller, KK; Nachtigall, L; Wexler, D, 2013)
"Temozolomide (TMZ) is an alkylating agent primarily used to treat tumors of the central nervous system."1.39Central diabetes insipidus: a previously unreported side effect of temozolomide. ( Faje, AT; Klibanski, A; Makimura, H; Miller, KK; Nachtigall, L; Wexler, D, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Faje, AT1
Nachtigall, L1
Wexler, D1
Miller, KK1
Klibanski, A1
Makimura, H1

Other Studies

1 other study available for temozolomide and Polydipsia

ArticleYear
Central diabetes insipidus: a previously unreported side effect of temozolomide.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:10

    Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Dacarbazine; Diabetes Insipi

2013